Home RxNorm 1494071 miltefosine 50 MG Oral Capsule Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1494071
RxNorm name miltefosine 50 MG Oral Capsule
Display name Miltefosine (Oral Pill)
Full name miltefosine 50 MG Oral Capsule
Term type SCD
Status Active
Strength 50 mg
Dose form Cap
Route Oral Pill
Updated 2026-10-04 02:02:29 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 052014
Active start 052014
Multiple ingredient NO
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength miltefosine 50 MG / 1 EACH miltefosine miltefosine
Derived Ingredient Concepts# Ingredient, RxCUI table Ingredient RxCUI miltefosine 1494066
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join IMPAVIDO MILTEFOSINE Profounda, Inc. bcb387ac-2e90-4f5e-94b2-d3635190678e 2026-09-30 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 1494071
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective bcb387ac-2e90-4f5e-94b2-d3635190678e miltefosine 50 MG Oral Capsule [PSN] · miltefosine 50 MG Oral Capsule [SCD] 2 13 These highlights do not include all the information needed to use IMPAVIDO safely and effectively. See full prescribing information for IMPAVIDO. IMPAVIDO (miltefosine) capsules, for oral use Initial U.S. Approval: 2014 20251218
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 50 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES SNOMEDCT 890469003 CODES VUID 4035637 NAMES Prescribable Synonym miltefosine 50 MG Oral Capsule SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source US Edition of SNOMED_CT SOURCES Source Veterans Health Administration National Drug File